A total scale of 30 billion! The first national-level mother fund in the foreign trade and economic field is being raised, introducing listed company LP Jinbo Bio and Joinn Laboratories.

① The Innovation and Development Guidance Fund for Service Trade is a national-level fund initiated by the Ministry of Finance, the Ministry of Commerce, and China Merchants Group, approved by the State Council, with a total scale of 30 billion yuan. ② An IR practitioner stated to the Star Daily that the second phase of the service trade fund inviting listed companies to become LPs may be a more market-oriented signal.

cls.cnDec 13 18:33

After investing 1.5 billion over three years to build a Global research and development headquarters, can Zhejiang Orient Gene Biotech win this "turnaround battle"?

① Zhejiang Orient Gene Biotech spent 0.29 billion yuan to acquire land in Zhangjiang, planning to build a global digital research and development innovation headquarters project with a total investment of 1.5 billion yuan, expected to achieve annual sales revenue of 1.5 billion yuan upon reaching production capacity. ② After the demand for nucleic acid testing declined, Zhejiang Orient Gene Biotech encountered a performance "slump", remaining in a net loss of over 260 million yuan until the first three quarters of 2024.

cls.cnDec 13 16:28

Jiangsu Hengrui Pharmaceuticals plans to list in Hong Kong! The hundred billion yuan pharmaceutical company ranks first among heavyweight in fund stocks in the A-share pharmaceutical sector.

On December 9, Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that, after the approval of the board of directors, in order to further assist the company's international business development, the company plans to issue shares (listed in hong kong) overseas and list on the main board of the Hong Kong Stock Exchange.

brokerage chinaDec 10 07:53

0.15 billion! Wuxi AppTec invested in a French VC, adding to the European biomedical market.

① Wuxi Apptec plans to invest in the "Jeito II S.L.P." fund, with a total target scale not exceeding 1.2 billion euros, and the fund is expected to invest in 14-17 medical innovative startups. ② Previously, Wuxi Apptec planned to invest 10 million euros in another well-known biotechnology investment institution in Europe, focusing on early-stage biomedical companies in Europe.

cls.cnDec 9 18:34

The chapter comes to a close! The final version of the NDAA in both the House and Senate did not include the biological security bill. Will it make a comeback next year?

1. The final negotiation text of NDAA did not include the "Biosecurity Act", and the attempt to "ride on the coattails" failed again; 2. This year, the session of the US Congress will come to an end, experts believe that the legislation of the "Biosecurity Act" this year may come to a conclusion, but it may "come back with a vengeance" next year.

cls.cnDec 9 07:33

This Thursday marks the start of the "soul negotiation" for medical insurance. Which companies are likely to be selected?

According to the National Medical Insurance Administration, a press conference will be held at 10 a.m. on November 28 at the National Medical Insurance Administration to announce the adjustments to the national medical insurance pharmaceutical catalog for 2024 and answer questions from reporters. This means that the results of the national negotiation for medical insurance centralized purchasing in 2024 will be announced this Thursday.

Securities TimesNov 26 19:39